Research into SARS-CoV-2
Abbexa is proud to offer an extensive range of products to support research into SARS-CoV-2
This includes our new COVID-19 test kit for professional use. This is a single-use in vitro diagnostic device used for laboratory and hospital testing. It detects IgG and IgM antibodies in blood against SARS-CoV-2, the virus that causes COVID-19. The presence of such antibodies indicates if exposure to a coronavirus has taken place, and whether it is a newer or older exposure. This all-inclusive kit produces fast, visual results in just 10 minutes.
The kit uses a procedure based on a lateral flow protocol. The cassette contains antigens from SARS-CoV-2 / COVID-19 conjugated to gold nanoparticles, which are collected by antibodies in the sample. Antibodies against human IgM and IgG are coated in their respective regions on a nitrocellulose membrane, where they create a coloured line due to the gold nanoparticles. A control region on the upper end of the cassette confirms if the test has been successful.
The readout should show 1 line in the C (control) region. Purple lines may appear next to the G (IgG) and M (IgM) regions depending on exposure to coronavirus. Faint lines are treated as a positive result.
You can find further information on this product and what to do with the results here
Abbexa are also pleased to offer hand sanitizers to our customers. Wash and/or sanitise your hands as often as possible. Our 75% ethanol hand sanitizer will leave your hands feeling fresh and clean.
Face masks can also be purchased for additional protection. A face mask offers protection in 2 ways: it protects other people by preventing any droplets from you, and it protects you from other people who are not wearing face masks and project their droplets onto you.
For other helpful tips, please see Abbexa's advice on staying safe in the crisis.
Please see our extensive range of other SARS-CoV-2 products for research below:
|COVID-19 IgG/IgM Rapid Test Kit For Professional Use For Professional Use||abx294171||View Here|
|SARS-CoV-2/COVID-19 RT-PCR Kit||abx460001||View Here|
SARS-CoV-2 Recombinant Proteins
|SARS-CoV-2/COVID-19 3C-like Proteinase||abx163962||View Here|
|SARS-CoV-2/COVID-19 S Protein RBD||abx163963||View Here|
|SARS-CoV-2/COVID-19 S Protein RBD||abx163964||View Here|
|SARS-CoV-2/COVID-19 S Protein RBD-SD1||abx163965||View Here|
|SARS-CoV-2/COVID-19 S Protein RBD-SD1||abx163966||View Here|
|SARS-CoV-2/COVID-19 S1 Protein||abx163967||View Here|
|SARS-CoV-2/COVID-19 S1 Protein||abx163968||View Here|
|SARS-CoV-2/COVID-19 S1 Protein||abx163969||View Here|
|SARS-CoV-2/COVID-19 S1 Protein||abx163970||View Here|
|SARS-CoV-2/COVID-19 S1 Protein CTD||abx163971||View Here|
|SARS-CoV-2/COVID-19 S Protein NTD||abx163972||View Here|
|SARS-CoV-2/COVID-19 Nucleocaspid Protein||abx163973||View Here|
|SARS-CoV-2/COVID-19 Nucleoprotein NTD Domain||abx163974||View Here|
|SARS-CoV-2/COVID-19 Nucleoprotein CTD Domain||abx163975||View Here|
|SARS-CoV-2/COVID-19 Envelope Protein||abx163976||View Here|
|SARS-CoV-2/COVID-19/2019-nCoV Nucleoprotein||abx600062||View Here|
|SARS-CoV-2/COVID-19/2019-nCoV Spike Glycoprotein||abx600064||View Here|
SARS-CoV-2 Related Targets
|Sars-Cov, Spike (N-Term) Recom Protein||abx060657||View Here|
|Sars-Cov, Spike (Middle) Recom Protein||abx060656||View Here|
|SARS-Cov Spike Protein (Recombinant)||abx060655||View Here|
|SARS-Cov E Protein (Recombinant)||abx060650||View Here|
|SARS-CoV Nucleocapsid Protein (Recombinant)||abx060652||View Here|
|SARS-CoV Nucleocapsid Protein (Recombinant)||abx060653||View Here|
|SARS-CoV Nucleocapsid Protein (Recombinant)||abx060654||View Here|
|SARS-CoV Spike Protein Antibody||abx023139||View Here|
|SARS-CoV Spike Protein Antibody||abx023143||View Here|
|BCoV Spike Protein Antibody||abx300551||View Here|
|HCoV-OC43 Spike Protein Antibody||abx109271||View Here|
|Aminopeptidase N / CD13 (ANPEP) Antibody||abx318265||View Here|
|Dipeptidyl Peptidase 4 (DPP4) Antibody||abx338829||View Here|
|Angiotensin Converting Enzyme 2 (ACE2) Antibody||abx032686||View Here|